1,002 results on '"Touw, Daan J"'
Search Results
2. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs
3. Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort
4. Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer
5. Comment on: “CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients”
6. Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?
7. Self-reported smoking, urine cotinine, and risk of type 2 diabetes: Findings from the PREVEND prospective cohort study
8. Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
9. Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan
10. Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND
11. A Joint Pharmacokinetic Model for the Simultaneous Description of Plasma and Whole Blood Tacrolimus Concentrations in Kidney and Lung Transplant Recipients
12. Effects of Plasmapheresis on Serum Lithium Levels in an ICU Patient with Bipolar Disorder: A Case Study
13. Safety, tolerability and toxicokinetics of the novel mitochondrial drug SUL-138 administered orally to rat and minipig
14. Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease
15. Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo
16. Central Body Fat Distribution and Kidney Function after Living Kidney Donation
17. The Impact of an Active Laboratory Approach on Therapeutic Drug Monitoring
18. Representation of older patients in the safety analysis of protein kinase inhibitor registration studies
19. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring
20. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study
21. Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan
22. Expeditious quantification of plasma tacrolimus with liquid chromatography tandem mass spectrometry in solid organ transplantation
23. Gentamicin Administration in Dialysis Patients: Before or After Hemodialysis?
24. Cobicistat as a Potential Booster of Ponatinib and Dasatinib Exposure in a CML Patient: A Case Study
25. Baclofen Stability up to One Year in In Vivo Intrathecal Infusion Pumps
26. Poor solubility and stability of rapamycin in aqueous environments
27. Medication Adherence Monitoring Using Alternative Sample Matrices: Bridging the Gap Between Analytical Validation and Clinical Interpretation
28. Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure
29. #910 Pharmacometabolomics identified nonactivated metabolites of azathioprine and mycophenolate mofetil in urine of kidney transplant recipients
30. #2852 Iron status and incident diabetes in kidney transplant recipients
31. Subtherapeutic exposure of ganciclovir in children despite appropriate dosing: a short communication
32. Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity
33. Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models.
34. Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays
35. Clinical Value of Emerging Bioanalytical Methods for Drug Measurements: A Scoping Review of Their Applicability for Medication Adherence and Therapeutic Drug Monitoring
36. Gentamicin Administration in Dialysis Patients: Before or After Hemodialysis?
37. Use of Salivary Iodine Concentrations to Estimate the Iodine Status of Adults in Clinical Practice
38. Effect of plasmapheresis on drug pharmacokinetics in children: a structured review of the current literature
39. Effects of interrupting the enterohepatic circulation in amatoxin intoxications
40. Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes
41. Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors
42. Plasma cadmium is associated with increased risk of long-term kidney graft failure
43. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia
44. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-Aand HLA-Bwith anti-epileptic drugs
45. A fast and simple method for the simultaneous analysis of midazolam, 1-hydroxymidazolam, 4-hydroxymidazolam and 1-hydroxymidazolam glucuronide in human serum, plasma and urine
46. 342.4: Inadequate Iodine Intake and Long-term Outcomes After Kidney Transplantation
47. 245.1: Tremor, Daily Functioning, and Quality of Life in Solid Organ Transplant Recipients
48. Comparison of two methods for the assessment of intra-erythrocyte magnesium and its determinants: Results from the LifeLines cohort study
49. Lessons learned from site-specific sampling and biological half-life of IGFII and IIE(68-88) peptide: a case study.
50. Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.